Allen B J, Corderoy-Buck S, Mallesch J L, Crotty K, Moore D E
Biomedicine and Health Program, Australian Nuclear Science and Technology Organisation, Menai, NSW.
Melanoma Res. 1992 Nov;2(4):253-62. doi: 10.1097/00008390-199211000-00006.
The systemic administration of enriched [10B]D,L-p-boronophenylalanine results in the selective uptake of boron by Harding-Passey melanoma xenografts in the nude mouse model. The boron-10 located in the tumour cells acts as a radiation sensitizer for thermal neutron irradiation. The nude mouse model can be successfully used to demonstrate that regression and local control of melanoma can be achieved by neutron capture therapy. Control is a manifestation of the high linear energy transfer radiation released after neutron capture by boron-10, and does not result from an equal fluence of neutrons alone. Histological examination of remnant tumour beds 300 days after treatment shows the presence of isolated melanoma cells. However, these cells are few in number and appear incapable of division.
在裸鼠模型中,全身给予富集的[10B]D,L-对硼苯丙氨酸会导致哈丁-帕西黑色素瘤异种移植物选择性摄取硼。位于肿瘤细胞中的硼-10可作为热中子辐照的辐射增敏剂。裸鼠模型可成功用于证明通过中子俘获疗法可实现黑色素瘤的消退和局部控制。这种控制是硼-10俘获中子后释放的高线性能量转移辐射的一种表现,并非仅由同等通量的中子所致。治疗后300天对残余肿瘤床的组织学检查显示存在孤立的黑色素瘤细胞。然而,这些细胞数量很少,且似乎无法分裂。